vasotocin (Acher et al., 1995) and the mechanisms regulating the physiological responses to arginine-vasotocin and oxytocin appear to be conserved across classes of vertebrate. For example, arginine-vasotocin activates phospholipase C in the uterus of two species of reptile and the response develops similarly near the time of oviposition or parturition (Mirando and Guillette, 1991) . Oviposition in birds is also associated with increased concentrations of arginine-vasotocin and PGF 2α in the peripheral circulation and the induction of oviposition by arginine-vasotocin in birds may be mediated by secretion of prostaglandins (Olson et al., 1986; Saito et al., 1987) . These mechanisms appear to be similar to those commonly shared among mammalian species during parturition (Fuchs et al., 1995; López Bernal et al., 1995) .
In addition to its role in parturition (Jenkins and Nussey, 1991; Fuchs et al., 1995; López Bernal et al., 1995) , Effects of arginine-and lysine-vasopressin on phospholipase C activity, intracellular calcium concentration and prostaglandin F 2α secretion in pig endometrial cells oxytocin is also involved in regulation of the oestrous cycle of domestic ungulates by stimulating release of the uterine luteolysin, PGF 2α (Silvia et al., 1991; Mirando et al., 1996; McCracken et al., 1999) . Oxytocin induces pulsatile secretion of PGF 2α during late dioestrus in sheep (Hooper et al., 1986) , an event that is required to promote luteolysis (Schramm et al., 1983; Zarco et al., 1988) . In pigs, endometrial responsiveness to oxytocin develops before luteolysis is initiated during late dioestrus (Carnahan et al., 1996; Edgerton et al., 1996) . Responsiveness is maximal in stromal cells, intermediate in glandular epithelial cells and not evident in luminal epithelial cells (Uzumcu et al., 1998; Braileanu et al., 1999) , although this cellular pattern of response to oxytocin is opposite to that which occurs in endometrium from mares and cows (Watson et al., 1992; Asselin et al., 1996) . All placental mammals from families other than Suidae apparently produce only arginine-vasopressin. In contrast, pigs are reported to express arginine-vasopressin in the corpus luteum (Pitzel et al., 1984; Choy and Watkins, 1988) and lysine-vasopressin in the central nervous system (Popenoe et al., 1952; Heller, 1960) . Structurally, lysinevasopressin and arginine-vasopressin differ only in possessing lysine or arginine, respectively, at position 8; oxytocin has leucine at position 8 and isoleucine in position 3 (Heller, 1960) . Type one vasopressin (V 1 ) receptors are apparently present in pig endometrium, as argininevasopressin and lysine-vasopressin induce phospholipase C activity in endometrial explants, although neither peptide promotes PGF 2α secretion (Whiteaker et al., 1994; Ludwig et al., 1998) . However, it is not known which cell types are responsive to arginine-and lysine-vasopressin. Therefore, the aim of the present study was to determine the effects of lysine-and arginine-vasopressin on phospholipase C activity, [Ca 2+ ] i and PGF 2α secretion in enriched populations of stromal, glandular epithelial and luminal epithelial cells collected from pig endometrium on day 16 of the oestrous cycle.
Materials and Methods

Animals
Peripubertal crossbred gilts (Yorkshire, Landrace, Large White, Duroc and Hampshire) were observed daily for standing oestrous behaviour in the presence of an intact boar and onset of second oestrus was designated as day 0. Hysterectomy was performed on day 16 after second or third oestrus as described by Whiteaker et al. (1994) and Ludwig et al. (1998) . Endometrium (20-25 g) was collected aseptically from one randomly selected uterine horn and placed in incomplete Hank's balanced salt solution.
Cells
Enriched populations of stromal, glandular epithelial and luminal epithelial cells were obtained using differential enzyme digestion and sieve separation as described by Zhang et al. (1991) and modified subsequently by Uzumcu et al. (1998) and Braileanu et al. (1999) . Cellular viability at plating, determined by trypan blue exclusion, was approximately 97, 86 and 93% for the enriched populations of stromal, glandular epithelial and luminal epithelial cells, respectively. Medium (RPMI-1640; Gibco BRL, Grand Island, NY) was supplemented with 20% fetal bovine serum (Gibco BRL) for luminal epithelial cells and with 10% fetal bovine serum for glandular epithelial and stromal cells. Medium was replaced after 3 days with fresh medium containing 5% fetal bovine serum. On the next day, the medium was replaced with fresh serum-free medium and experiments were performed. The purity of the cell populations was determined by immunofluorescent staining for cytokeratin (Uzumcu et al., 1998) and exceeded 95, 90 and 97% for the stromal, glandular epithelial and luminal epithelial cells, respectively.
Experiment 1
Activity of phospholipase C in stromal, glandular epithelial and luminal epithelial cells was examined in response to treatment with control vehicle, 100 nmol oxytocin l -1 (Sigma Chemical Co., St Louis, MO), 100 nmol arginine-vasopressin l -1 (Sigma), 100 nmol lysine-vasopressin l -1 (Sigma) or 100 nmol GnRH l -1 (Bachem California, Torrance, CA) for 30 min. Cells from seven gilts were used and each treatment was performed on duplicate wells for each cell type. Oxytocin and GnRH served as positive and negative controls, respectively. Phospholipase C activity was measured by incorporation of [ 3 H]inositol into total inositol phosphates as described previously (Whiteaker et al., 1994; Ludwig et al., 1998; Uzumcu et al., 1998) . In brief, the medium was replaced at the end of the 30 min treatment period with 1 ml ice-cold 15% (w/v) trichloroacetic acid and the cells were placed on ice for 20 min. The cell lysates were then collected and analysed for incorporation of [ 3 H]inositol into total inositol phosphates by anion exchange chromatography. Data for activity of phospholipase C were expressed as total 
Experiment 2
In Expt 2, [Ca 2+ ] i was measured in individual stromal, glandular epithelial and luminal epithelial cells in response to 100 nmol oxytocin l -1 , 100 nmol arginine-vasopressin l -1 or 100 nmol lysine-vasopressin l -1 . The cells were washed with serum-free RPMI-1640 and loaded with fluorescent Ca 2+ indicator, Fura-2 am (1 µmol l -1 ) (Molecular Probes, Eugene, OR) in buffer (140 mmol NaCl l -1 , 5 mmol KCl l -1 , 2 mmol CaCl 2 l -1 , 1 mmol MgCl 2 l -1 , 10 mmol Hepes l -1 and 6 mmol glucose l -1 , pH 7.4) containing 0.04% (v/v) pluronic acid F-127 (Molecular Probes) for 30 min at room temperature. The cells were washed with buffer for an additional 30 min before quantification of [Ca 2+ ] i as described by Braileanu et al. (1999) . Buffer or oxytocin, arginine-vasopressin or lysinevasopressin dissolved in buffer was administered at a constant flow rate of 5 ml min -1 . Treatments were performed at room temperature and consisted of 90 s pulses that were applied at different intervals. Cells from five different pigs were used and 1-3 coverslips (у 15 cells per coverslip) per pig were analysed for each cell type. Pairs of images with excitation light at 340 nm and 380 nm and emission light at 510 nm were taken every 6 s with a CCD camera and analysed using the MetaFluor Imaging System Software (Universal Imaging Corp., West Chester, PA). Images were corrected for background fluorescence and the ratio values from individual cells within the image were converted to [Ca 2+ ] i using a standard curve generated in 150 mmol KCl/Hepes buffer l -1 (pH 7.4) using EGTA and CaCl 2 . Fluorescent image intensities during oxytocin exposure were monitored periodically to ensure that [Ca 2+ ] i changes were due to reciprocal changes in the fluorescent intensities at 340 and 380 nm.
Experiment 3 PGF 2α secretion from stromal, glandular epithelial and luminal epithelial cells was measured in response to treatment for 3 h with control vehicle, 100 nmol oxytocin l -1 , 100 nmol arginine-vasopressin l -1 , 100 nmol lysinevasopressin l -1 or 100 nmol GnRH l -1 . Cells from ten gilts were used and each treatment was performed in quadruplicate for each cell type. Concentrations of PGF 2α in 25 µl medium were quantified by radioimmunoassay as described by Whiteaker et al. (1994) and Uzumcu et al. (1998) . Intra-and interassay coefficients of variation were 6.4 and 16.5%, respectively.
Experiment 4
Stromal cells from five gilts were treated with 0, 33, 100 and 333 nmol arginine-vasopressin l -1 for 3 h to confirm the effects of 100 nmol arginine-vasopressin l -1 on phospholipase C activity and PGF 2α secretion by stromal cells that were observed in Expts 1 and 3, respectively. Cellular phospholipase C activity and PGF 2α secretion were determined as described for Expts 1 and 3, respectively.
Experiment 5
Stromal cells from four gilts were treated with 100 nmol oxytocin l -1 or 100 nmol arginine-vasopressin l -1 in the presence or absence of 100 nmol oxytocin antagonist l -1 (L-366,948; Merck, Sharp and Dohme Research Laboratories, West Point, PA) to investigate whether the response of stromal cells to arginine-vasopressin was mediated through oxytocin receptors. [Ca 2+ ] i was measured as described for Expt 2. Exposure to oxytocin antagonist was initiated 90 s before oxytocin or arginine-vasopressin treatment and continued for the duration of agonist treatment.
Stromal cells from these same gilts were exposed sequentially to oxytocin and arginine-vasopressin to determine whether prior exposure to one peptide desensitized the response to the other peptide. Cells were treated with 100 nmol oxytocin l -1 for 60 s and were treated subsequently with 100 nmol arginine-vasopressin l -1 for 90 s starting 120 s after removal of oxytocin. Additional wells of cells were treated first with 100 nmol argininevasopressin l -1 for 60 s and then with 100 nmol oxytocin l -1 for 60 s starting 90 s after removal of arginine-vasopressin.
Statistical analyses
Data from all experiments were subjected to least squares ANOVA using the General Linear Models procedure of the Statistical Analysis System (SAS System for Windows 6.12, SAS Institute Inc., Cary, NC). Preplanned comparisons were performed using the PDIFF option within the LSMEANS statement of the General Linear Models procedure. Least squares means and appropriate standard errors were generated from the ANOVA using the LSMEANS statement.
Results
Experiment 1
Oxytocin increased phospholipase C activity in stromal cells (P < 0.01, Fig. 1a ) and glandular epithelial cells (P < 0.05, Fig. 1b ), but not in luminal epithelial cells (Fig. 1c) . In stromal cells, arginine-vasopressin increased (P < 0.05) phospholipase C activity (Fig. 1a) , but the increase was less (P < 0.01) than that for oxytocin. Activity of phospholipase C was not increased by arginine-vasopressin in either glandular or luminal epithelial cells (Fig. 1b,c, respectively) . Neither lysine-vasopressin nor GnRH altered phospholipase C activity in any cell type.
Experiment 2
In stromal cells, oxytocin induced a synchronous and transient increase in [Ca 2+ ] i (P < 0.01) in 95% of the cells analysed (n = 150 total cells, Fig. 2a) . Administration of arginine-vasopressin to stromal cells increased [Ca 2+ ] i (P < 0.01); however, the mean amplitude of the peak and the proportion of cells responding were less (P < 0.01) than that for oxytocin. Treatment with lysine-vasopressin did not alter [Ca 2+ ] i in stromal cells (Fig. 2a) . The effects of argininevasopressin and lysine-vasopressin were similar regardless of the order in which treatments were administered (Fig.  2b) . In glandular epithelial cells, oxytocin induced a smaller increase in [Ca 2+ ] i (Fig. 2c) and did not influence [Ca 2+ ] i in luminal epithelial cells (data not shown). Neither argininevasopressin nor lysine-vasopressin increased [Ca 2+ ] i in glandular (Fig. 2c) or luminal epithelial cells (data not shown).
Experiment 3
Oxytocin increased PGF 2α secretion from stromal cells (P < 0.05) and glandular epithelial cells (P = 0.06) but not from luminal epithelial cells (Fig. 3a,b,c, respectively) . For stromal cells, arginine-vasopressin also stimulated (P < 0.05) PGF 2α secretion (Fig. 3a) . However, arginine-vasopressin did not alter PGF 2α release from either glandular or luminal epithelial cells (Fig. 3b,c, respectively) . Neither lysinevasopressin nor GnRH altered PGF 2α secretion from any cell type.
Experiment 4
Oxytocin increased phospholipase C activity (P < 0.01) and PGF 2α secretion (P < 0.05) in stromal cells (Fig. 4a,b , respectively). Activity of phospholipase C and PGF 2α secretion were increased by arginine-vasopressin in a concentration-dependent manner; phospholipase C activity was stimulated by 33 nmol arginine-vasopressin l -1 (P < 0.05), 100 nmol arginine-vasopressin l -1 (P < 0.01) and 333 nmol arginine-vasopressin l -1 (P < 0.01), but the increases at all the concentrations of arginine-vasopressin examined were less than those promoted by oxytocin (P < 0.05) (Fig. 4a) . Secretion of PGF 2α was stimulated by 100 nmol arginine-vasopressin l -1 (P < 0.06) and 333 nmol arginine-vasopressin l -1 (P < 0.05), but the increase resulting from 100 nmol arginine-vasopressin l -1 was less (P < 0.05) than that promoted by 100 nmol oxytocin l -1 (Fig. 4b) .
Experiment 5
Exposure of stromal cells to oxytocin increased [Ca 2+ ] i (P < 0.01; 902 Ϯ 52 nmol l -1 , n = 70 total cells; Fig. 5a ), whereas the increase in [Ca 2+ ] i caused by argininevasopressin (P < 0.05; 407 Ϯ 39 nmol l −1 , n = 83 total cells; Fig. 5c ) was less (P < 0.05) than that caused by oxytocin. In the presence of the oxytocin antagonist L-366,968, the [Ca 2+ ] i response to oxytocin was significantly reduced (P < 0.05; 338 Ϯ 49 nmol l −1 ; Fig. 5a ). The effect of the oxytocin antagonist was reversible as the oxytocin response recovered after the antagonist was washed from the cells (Fig. 5a ). The oxytocin antagonist also reduced the [Ca 2+ ] i response to arginine-vasopressin (P < 0.05; 34 Ϯ 9 nmol l -1 , n = 34 total cells; Fig. 5b ). When cells were challenged with arginine-vasopressin within 2 min after a challenge to oxytocin, the [Ca 2+ ] i , response to arginine-vasopressin was virtually eliminated (P < 0.05; 19 Ϯ 5 nmol l -1 , n = 29 total cells; Fig. 6a ). However, exposure of stromal cells to arginine-vasopressin before oxytocin did not significantly affect the calcium response to oxytocin (856 Ϯ 64 nmol l -1 , n = 41 total cells; Fig. 6b ). Receptors for oxytocin and vasopressin have been cloned and shown to be highly homologous members of a subfamily within the superfamily of G protein-linked receptors (Zingg, 1996) . Oxytocin receptors and phospholipase C-linked V 1 receptors are present together in several tissues, including the uterus (Chen et al., 1999) , although information regarding the spatial and temporal expression of V 1 receptors in the endometrium of ungulates is currently unavailable. However, three lines of evidence from the present results support the contention that the actions of oxytocin and argininevasopressin on pig endometrial cells occur through specific oxytocin receptors, rather than V 1 receptors. Firstly, the [Ca 2+ ] i response to arginine-vasopressin was attenuated markedly by the selective oxytocin antagonist L-366,968. The response to oxytocin was also reduced by L-366,968, an effect that was reversible. Secondly, oxytocin completely desensitized the response to arginine-vasopressin when arginine-vasopressin was applied within 2 min of oxytocin treatment. Similarly, oxytocin completely desensitized the response to subsequent oxytocin treatments that occurred within 5 min of the first exposure (Braileanu et al., 1999) . In contrast, oxytocin and angiotensin II were unable to desensitize the response to each other but did desensitize their own response in a homologous manner (Braileanu et al., 1998) . These results indicate that oxytocin and argininevasopressin acted through the same receptors, whereas oxytocin and angiotensin II acted through two distinct receptor populations. Finally, stromal cells were responsive to arginine-vasopressin but were completely unresponsive to lysine-vasopressin. It seems extremely unlikely that stromal cells possess V 1 receptors, which can discriminate between the subtle structural difference between arginine-vasopressin and lysine-vasopressin, as lysine-vasopressin is the principal vasopressin molecule secreted in pigs (Heller, 1960) . Such an ability of V 1 receptors to discriminate between lysinevasopressin and arginine-vasopressin would prevent lysinevasopressin from activating these receptors in other tissues as well. Collectively, these results indicate that argininevasopressin acted through oxytocin receptors in the present study. Previous studies with endometrial explants in pigs showed that lysine-vasopressin and arginine-vasopressin increased phospholipase C activity to a similar extent as did oxytocin, but did not increase PGF 2α secretion (Whiteaker et al., 1994; Ludwig et al., 1998) . In the present study, arginine-vasopressin stimulated phospholipase C activity, intracellular [Ca 2+ ] i and PGF 2α secretion in stromal cells only, whereas all cell types were completely unresponsive to lysine-vasopressin. These apparently conflicting results can be reconciled readily by the facts that stromal cells comprise only a portion of the cells in the endometrium and that V 1 receptors may be present on cells other than stromal cells, such as blood vessel endothelial cells (Conklin et al., 1999; Thibonnier et al., 1999) . Alternatively, the inability to detect an arginine-vasopressin-induced increase in PGF 2α secretion in previous studies (Ludwig et al., 1998 ) is probably because arginine-vasopressin-responsive stromal cells represent only a portion of the endometrium and glandular and luminal epithelial cells secrete at least twice as much PGF 2α per cell as do stromal cells (Uzumcu et al., 1998) . Therefore, the high basal secretion of PGF 2α from arginine-vasopressin-unresponsive cells in endometrial explants may have obscured the stimulatory effect of arginine-vasopressin on enriched stromal cells that was detected in the present study. All effects of arginine-vasopressin on stromal and glandular epithelial cells in the present study were considerably less than the effects of oxytocin. This finding is probably attributable to the documented crossreactivity of arginine-vasopressin with oxytocin receptors (Whiteaker et al., 1994; Rahmani et al., 1997; Chen et al., 1999) rather than through an action on V 1 receptors, as discussed previously. However, stromal and glandular epithelial cells were completely unresponsive to the concentration of lysine-vasopressin (100 nmol l -1 ) that was used in the present study. Similarly, oxytocin was reported to be 50-75 times more potent than lysine-vasopressin in activating oxytocin receptors on pig myometrium (Yu et al., 1995) . Thus, the evolution of lysine-vasopressin in pigs appears to provide increased selectivity of oxytocin receptors for oxytocin over lysine-vasopressin compared with their relative inability to discriminate between oxytocin and arginine-vasopressin in other mammalian species.
Discussion
Although the roles of lysine-vasopressin and argininevasopressin at the central or circulatory level are established (for example, vasoconstriction, liver glycogenolysis, platelet adhesion, adrenal secretion of angiotensin II and certain brain functions), it is not clear what roles they play within the uterus. In myometrium, vasopressin may mediate contractility (Yu et al., 1995; Åkerlund et al., 1998) , whereas in endometrium it may mediate the release of PGF 2α or other uterotonic substances, such as endothelin (Maggi et al., 1997) . For example, arginine-vasopressin increased PGF 2α secretion from cultured vascular smooth muscle cells (Tahara et al., 1997) . The results of the present study indicate that arginine-vasopressin may also promote PGF 2α production in stromal cells of pig endometrium although the physiological role of arginine-vasopressin in this tissue is not clear. Regardless, the possibility that vasopressin acts as an antagonist of oxytocin action in pig endometrium was excluded because 100 nmol lysinevasopressin l -1 did not reduce oxytocin-stimulated phospholipase C activity in endometrial explants; on the contrary, the stimulatory actions of lysine-vasopressin and oxytocin when applied together were additive (Ludwig et al., 1998) . Similarly, ongoing studies have indicated that 1 µmol lysine-vasopressin l -1 did not antagonize the action of 100 nmol oxytocin l -1 in endometrial explants from pigs (J. Hu, T. E. Ludwig and M. A. Mirando, unpublished) .
In ruminants, endometrial expression of oxytocin receptors increases markedly during late dioestrus (Roberts et al., 1976; Ayad et al., 1991; Mirando et al., 1993; Stevenson et al., 1994) , particularly in the luminal epithelium on which oxytocin receptors first appear as the luteolytic mechanism develops (Ayad et al., 1991; Stevenson et al., 1994) . Development of endometrial responsiveness to oxytocin coincides with the temporal increase in oxytocin receptor expression (Roberts et al., 1976; Mirando et al., 1993) and epithelial cells are the predominant cell type responsive to oxytocin (Asselin et al., 1996) . However, the results of the present study confirmed those of Uzumcu et al. (1998) and Braileanu et al. (1999) , who reported that stromal cells from pig endometrium were most responsive to oxytocin, luminal epithelial cells were completely unresponsive and glandular epithelial cells had an intermediate response. This occurred despite the fact that epithelial cells of pig endometrium expressed a greater number of receptors for oxytocin than did stromal cells during dioestrus (Boulton et al., 1995) . Thus, the pattern of response to oxytocin among cell types in pigs is opposite to that of endometrium from other ungulate species, in which epithelial cells secrete more PGF 2α in response to oxytocin than do stromal cells (horses: Watson et al., 1992; cows: Asselin et al., 1996) . It appears that this pattern of response to oxytocin among the cell types described in the present and previous (Uzumcu et al., 1998; Braileanu et al., 1999) studies may reflect their physiological state in vivo, as stromal cells were similarly responsive to oxytocin during 12 h-12 days in culture and responsiveness of both epithelial cell types did not increase after several additional days of culture (G. T. Braileanu, S. M. Simasko, and M. A. Mirando, unpublished). However, the functional significance of this difference among species is not clear.
In conclusion, these results indicate that stromal cells isolated from pig endometrium on day 16 after oestrus are most responsive to oxytocin, less sensitive to argininevasopressin and completely unresponsive to lysinevasopressin. However, both glandular and luminal epithelial cells are completely unresponsive to argininevasopressin and lysine-vasopressin. Collectively, these results indicate that oxytocin receptors can bind argininevasopressin more readily than lysine-vasopressin. The physiological role of arginine-vasopressin in pig endometrial stromal cells remains to be determined.
